期刊
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
卷 60, 期 2, 页码 120-125出版社
WILEY
DOI: 10.1111/dmcn.13483
关键词
-
资金
- National Institute of Neurological Disorders and Stroke [5U01NS040069-05, 2R01NS040069-06A2]
- National Eye Institute [1-R01-EY021820-01]
- National Institute of Child Health and Human Development [5P30HD018655-28]
- Wellcome Trust [WT094823]
- Inserm
- Universite Paris 7
- Fondation Leducq [DSRR_P34404]
- Fondation Grace de Monaco
- Fondation Roger de Spoelberch
- PremUP
- VR [2012-3500]
- ALFGBG [137601]
- Fondation des Gueules Cassees
- European Union [HEALTH-F2-2009-241778/Neurobid]
- Burton E. Green Endowment
Brain injury in preterm newborn infants is often attributed to hypoxia-ischemia even when neither hypoxia nor ischemia is documented, and many causative speculations are based on the same assumption. We review human and animal study contributions with their strengths and limitations, and conclude that - despite all the work done in human fetal neuropathology and developmental models in animals - the evidence remains unconvincing that hypoxemia, in the fetus or newborn infant, contributes appreciably to any encephalopathy of prematurity. Giving an inappropriate causal name to a disorder potentially limits the options for change, should our understanding of the etiologies advance. The only observationally-based title we think appropriate is 'encephalopathy of prematurity'. Future pathophysiological research should probably include appropriately designed epidemiology studies, highly active developmental processes, infection and other inflammatory stimuli, the immature immune system, long chain fatty acids and their transporters, and growth (neurotrophic) factors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据